Physician profile
Jason E Falcone
NPI 1487615571
$5,358.48
in general payments reported to CMS, 2019-2025
44 companies · $807 in 2025
The $807 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $1,845 · 2023: $1,571 · 2024: $967 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,151 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,151.14 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $810.29 | 2022 | |
| Astellas Pharma US INC | $551.60 | 2022-2024 | Myrbetriq, Xtandi |
| Myriad Genetic Laboratories, INC. | $400.72 | 2021-2025 | Prolaris |
| Janssen Biotech, INC. | $306.35 | 2022-2025 | Erleada |
| Antares Pharma, INC. | $288.80 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Urovant Sciences INC | $236.18 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $221.43 | 2023-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $196.87 | 2022-2024 | Keytruda, Lynparza |
| Coloplast Corp | $182.89 | 2023-2025 | Speedicath |
| Ferring Pharmaceuticals INC. | $172.71 | 2024-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $157.35 | 2021-2022 | |
| Urogen Pharma, INC. | $132.80 | 2022-2024 | Jelmyto |
| 180 Medical, INC. | $128.78 | 2022-2024 | Gentlecath Glide |
| Pfizer INC. | $105.00 | 2021-2023 | |
| Abbvie INC. | $92.91 | 2024-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $91.82 | 2025 | |
| Olympus America INC. | $85.85 | 2022-2024 | Itind System |
| Dendreon Pharmaceuticals LLC | $84.50 | 2025 | Provenge |
| Axonics, INC. | $82.81 | 2023-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $81.65 | 2023-2024 | Xiaflex, Edex, Aveed |
| Immunitybio, INC. | $80.19 | 2024-2025 | |
| Tolmar, INC. | $79.62 | 2023-2025 | Jatenzo, Eligard |
| Endo USA, INC. | $73.78 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $66.42 | 2022 | |
| Halozyme INC | $61.59 | 2023 | |
| Medtronic, INC. | $52.44 | 2025 | Interstim, Altaviva |
| Telix Pharmaceuticals | $49.32 | 2023-2024 | Illuccix |
| Dentsply Ih Ab | $49.01 | 2025 | Lofric |
| Bayer Healthcare Pharmaceuticals INC. | $48.83 | 2021-2024 | |
| Agiliti Surgical, INC. | $45.01 | 2023 | Sonablate |
| Astrazeneca Pharmaceuticals LP | $42.10 | 2021-2025 | Lynparza |
| Alnylam Pharmaceuticals INC. | $39.96 | 2024-2025 | Givlaari |
| Hollister Incorporated | $39.58 | 2022 | |
| Foundation Medicine, INC. | $37.01 | 2023 | |
| Amgen INC. | $31.57 | 2022 | |
| Progenics Pharmaceuticals, INC. | $23.57 | 2023 | Pylarify |
| Blue Earth Diagnostics | $19.85 | 2024 | |
| Verity Pharmaceuticals INC. | $17.62 | 2023 | Trelstar |
| Accord Healthcare, INC. | $17.35 | 2025 | |
| Clarus Therapeutics INC. | $16.37 | 2021 | |
| Boston Scientific Corporation | $15.23 | 2025 | Axonics |
| Otsuka America Pharmaceutical, INC. | $15.00 | 2023 | Jynarque |
| Bioprotect Medical, INC. | $14.26 | 2024 | Bioprotect Balloon Implant System |
| Palette Life Sciences, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Falcone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.